EP Patent

EP2996689A1 — Compounds for use as bromodomain inhibitors

Assigned to Albert Ludwigs Universitaet Freiburg · Expires 2016-03-23 · 10y expired

What this patent protects

A compound of formula (1 ), (1'), (1 ") or (1''') or a pharmaceutically acceptable salt thereof, for use in the treatment of diseases or conditions for which a bromodomain inhibitor is indicated.

USPTO Abstract

A compound of formula (1 ), (1'), (1 ") or (1''') or a pharmaceutically acceptable salt thereof, for use in the treatment of diseases or conditions for which a bromodomain inhibitor is indicated.

Drugs covered by this patent

Patent Metadata

Patent number
EP2996689A1
Jurisdiction
EP
Classification
—
Expires
2016-03-23
Drug substance claim
No
Drug product claim
No
Assignee
Albert Ludwigs Universitaet Freiburg
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.